What type of study is this?

This is a Human Clinical Trial study (also classified as: Pre-Registered Trial).

August 21, 2025European Journal of Preventive CardiologyOpen Access

Stopping antihypertensive Treatment amOng hypertensive patients in Primary care: The STOP-Trial

View Full Paper

Ask AI

Bookmark

About 36% of participants maintained blood pressure below 135/85 mmHg after stopping antihypertensive therapy for one year.
The primary outcome was maintaining normotension as assessed by home blood pressure measurements over 12 months.
This multicenter, open-label trial evaluated antihypertensive therapy discontinuation in selected individuals without additional cardiovascular risk factors.
The study highlights that discontinuing antihypertensive therapy may be feasible but requires close monitoring of blood pressure.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Prospective trial assessed normotension maintenance after stopping antihypertensive therapy in hypertensive patients, indicating selected discontinuation may be viable.

Cite This Study

Boivin et al. (2025) studied this question.

synapsesocial.com/papers/68af4ec6ad7bf08b1ead8179 https://doi.org/10.1093/eurjpc/zwaf511

View Full Paper

Ask AI

Bookmark

Implication

Prospective trial assessed normotension maintenance after stopping antihypertensive therapy in hypertensive patients, indicating selected discontinuation may be viable.

Stopping antihypertensive Treatment amOng hypertensive patients in Primary care: The STOP-Trial

Key Points

Discussion

Implication

Cite This Study

Stopping antihypertensive Treatment amOng hypertensive patients in Primary care: The STOP-Trial

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider